Frontlight ResearchEarly access
Trial site
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI)
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Epilepsy3 trials
- Atrial fibrillation1 trial
- Schizophrenia1 trial
- Stroke1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Biohaven Therapeutics Ltd.2 trials
- Bristol-Myers Squibb2 trials
- Eli Lilly and Company1 trial
- Epygenix1 trial
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease3 recruiting
- Epilepsy2 recruiting
- Schizophrenia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026